Patents by Inventor David Rodriguez Diaz

David Rodriguez Diaz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • LRRK2 INHIBITORS
    Publication number: 20230416272
    Abstract: The present invention is directed to compounds of formula I The compounds are considered useful for the treatment of diseases associated with LRRK2 such as Parkinson's disease.
    Type: Application
    Filed: June 8, 2023
    Publication date: December 28, 2023
    Applicant: H. Lundbeck A/S
    Inventors: Thomas Jensen, Mikkel Jessing, Wanwan Yu, David Rodriguez Diaz, Jacob Nielsen, Christopher Richard Jones, Thomas Andersen, Mikkel Fog Jacobsen
  • LRRK2 inhibitors
    Patent number: 11780851
    Abstract: The present invention is directed to compounds of formula I The compounds are considered useful for the treatment of diseases associated with LRRK2 such as Parkinson's disease.
    Type: Grant
    Filed: October 26, 2022
    Date of Patent: October 10, 2023
    Assignee: H. Lundbeck A/S
    Inventors: Thomas Jensen, Mikkel Jessing, Wanwan Yu, David Rodriguez Diaz, Jacob Nielsen, Christopher Richard Jones, Thomas Andersen, Mikkel Fog Jacobsen
  • LRRK2 INHIBITORS
    Publication number: 20230144725
    Abstract: The present invention is directed to compounds of formula I The compounds are considered useful for the treatment of diseases associated with LRRK2 such as Parkinson's disease.
    Type: Application
    Filed: October 26, 2022
    Publication date: May 11, 2023
    Applicant: H. Lundbeck A/S
    Inventors: Thomas Jensen, Mikkel Jessing, Wanwan YU, David Rodriguez Diaz, Jacob Nielsen, Christopher Richard Jones, Thomas Andersen, Mikkel Fog Jacobsen